Layton, J. Bradley http://orcid.org/0000-0003-0994-5820
Forns, Joan http://orcid.org/0000-0002-1066-0358
Turner, Mary Ellen
Dempsey, Colleen
Bartsch, Jennifer L. http://orcid.org/0000-0003-1506-5715
Anthony, Mary S. http://orcid.org/0000-0002-5201-1794
Danysh, Heather E. http://orcid.org/0000-0003-3014-7508
Ritchey, Mary E. http://orcid.org/0000-0003-0304-9304
Demos, George
Funding for this research was provided by:
acadia pharmaceuticals
Article History
Accepted: 6 October 2021
First Online: 30 October 2021
Declarations
:
: This work was funded by Acadia Pharmaceuticals.
: CD and MET are employees of Acadia Pharmaceuticals, which produces one of the medications evaluated in this study. GD was an employee of Acadia Pharmaceuticals while this work was performed. JBL, JF, JLB, MSA, and HED are employees of RTI Health Solutions. MER was an employee of RTI Health Solutions while this work was performed. This study was conducted by RTI Health Solutions with funding from Acadia Pharmaceuticals under a contract that included independent publication rights.
: This analysis of deidentified data was exempted from review by the Institutional Review Board of RTI International.
: Individual-level consent was not required for this analysis using deidentified secondary data.
: Individual-level consent was not required for this analysis of deidentified secondary data.
: The data that support the findings of this study were licensed from the IBM MarketScan Research Databases. These data are not publicly available. Any researcher requiring access to the raw data that were used to generate the analytical files can access the data under a license agreement, including the payment of appropriate license fees, between that third party and IBM.
: Researchers seeking to access the analytic code used in the analysis of this data may contact the study team.
: JBL: conceptualization, methodology, visualization, writing (original draft); JF: conceptualization, methodology, visualization, writing (original draft); CD: conceptualization, writing (review and editing); MET: conceptualization, funding acquisition, writing (review and editing); JLB: methodology, software, formal analysis, data curation, writing (review and editing); MSA: conceptualization, supervision, funding acquisition, writing (review and editing); HED: resources, project administration, writing (review and editing); MER: conceptualization, methodology, resources, visualization, supervision, project administration, funding acquisition, writing (review and editing); GD: conceptualization, writing (review and editing).